Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRHR | P34981 | 6/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Azetirelin SCHEMBL10703548 | 1.00 | TRHR (0.62) | TRHR | |
| Azetirelin SCHEMBL4958204 | 1.00 | TRHR (0.62) | TRHR | |
| Azetirelin SCHEMBL7265691 | 1.00 | TRHR (0.62) | TRHR | |
| Azetirelin SCHEMBL27999417 | 1.00 | TRHR (0.62) | TRHR | |
| Azetirelin SCHEMBL4960774 | 0.99 | TRHR (0.61) | TRHR | |
| Protirelin SCHEMBL2182035 | 0.92 | TRHR (0.71) | TRHR | |
| Protirelin SCHEMBL20659679 | 0.92 | TRHR (0.71) | TRHR | |
| Protirelin SCHEMBL14280929 | 0.92 | TRHR (0.71) | TRHR | |
| Protirelin SCHEMBL11798811 | 0.92 | TRHR (0.71) | TRHR | |
| Protirelin SCHEMBL8364920 | 0.92 | TRHR (0.71) | TRHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 462 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220133627-A1 | Stable Therapeutic Formulations | ALZA CORP (US) | 2022-05-05 | — | — | US | claimed |
| US-9421351-B2 | Self-actuating applicator for microprojection array | ALZA CORPORATION (US) | 2016-08-23 | — | — | US | claimed |
| US-8920817-B2 | Formulations for coated microprojections containing non-volatile counterions | ALZA CORPORATION (US) | 2014-12-30 | — | — | US | claimed |
| EP-1680154-B1 | SELF-ACTUATING APPLICATOR FOR MICROPROJECTION ARRAY | ALZA CORP (US) | 2012-01-04 | — | — | EP | claimed |
| US-20100221305-A1 | Formulations for coated microprojections containing non-volatile counterions | ALZA CORPORATION (US) | 2010-09-02 | — | — | US | claimed |
| US-20090117158-A1 | Transdermal sustained release drug delivery | ALZA CORPORATION | 2009-05-07 | — | — | US | claimed |
| EP-1981547-A4 | STABLE THERAPEUTIC FORMULATIONS | ALZA CORP (US) | 2009-05-06 | — | — | EP | claimed |
| WO-2009054988-A1 | TRANSDERMAL SUSTAINED RELEASE DRUG DELIVERY | ALZA CORPORATION (US) | 2009-04-30 | — | — | WO | claimed |
| EP-1981547-A2 | STABLE THERAPEUTIC FORMULATIONS | ALZA CORPORATION (US) | 2008-10-22 | — | — | EP | claimed |
| EP-1924364-A1 | COATABLE TRANSDERMAL DELIVERY MICROPROJECTION ASSEMBLY | Alza Corporation (US) | 2008-05-28 | — | — | EP | claimed |
| US-20050049549-A1 | Method and device for enhancing transdermal agent flux | ALZA CORPORATION | 2005-03-03 | — | — | US | claimed |
| WO-2005016440-A1 | METHOD AND DEVICE FOR ENHANCING TRANSDERMAL AGENT FLUX | ALZA CORPORATION (US) | 2005-02-24 | — | — | WO | claimed |
| WO-2005016441-A1 | METHOD AND DEVICE FOR ENHANCING TRANSDERMAL AGENT FLUX | ALZA CORPORATION (US) | 2005-02-24 | — | — | WO | claimed |
| US-20050031676-A1 | Method and device for enhancing transdermal agent flux | ALZA CORPORATION | 2005-02-10 | — | — | US | claimed |
| WO-2005004729-A1 | METHOD FOR COATING SKIN PIERCING MICROPROJECTIONS | ALZA CORPORATION (US) | 2005-01-20 | — | — | WO | claimed |
| WO-2005004842-A2 | FORMULATIONS FOR COATED MICROPROJECTIONS CONTAINING NON-VOLATILE COUNTERIONS | ALZA CORPORATION (US) | 2005-01-20 | — | — | WO | claimed |
| US-20040265365-A1 | Method for coating skin piercing microprojections | ALZA CORPORATION | 2004-12-30 | — | — | US | claimed |
| US-20040265354-A1 | Transdermal drug delivery device having stratum corneum-piercing microprojections; pH stability and solubility when dried; | ZOSANO PHARMA CORPORATION | 2004-12-30 | — | — | US | claimed |
| EP-0225796-A2 | Novel crystals of N alpha-[[(S)-4-oxo-2-azetidinyl]-carbonyl]-L-histidyl-L-prolinamide and process for producing the crystals | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1987-06-16 | — | — | EP | claimed |
| EP-0123444-A1 | 4-Substituted-2-azetidinone compound, process of producing the compounds, and medicaments containing the compounds | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1984-10-31 | — | — | EP | claimed |